Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas

Andrea Micheli, P. Baili, M. Quinn, E. Mugno, R. Capocaccia, P. Grosclaude, W. Oberaigner, J. Holub, M. Jechova, H. Storm, G. Engholm, T. Aareleid, T. Hakulinen, B. Soderman, P. Grosclaude, C. Spix, H. Ziegler, E. Olafsdottir, R. Capocaccia, A. MicheliP. Baili, E. Mugno, M. Dalmas, S. E. Tysvaer, Paulo Pinheiro, J. Rachtan, M. Bielska-Lasota, I. Plesko, V. Pompe-Kirn, I. Izarzugaza, C. Martinez-Garcia, I. Garau, C. Navarro, L. Cirera, E. Ardanaz, C. Moreno, J. Galceran, L. Barlow, P. Pury, M. Usel, O. Visser, J. W.W. Coebergh, L. Van Der Heijden, L. Bhatti, M. J. Quinn, P. Babb

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Mortality information is essential for estimating relative cancer survival (that excludes deaths from other causes). However, sufficiently detailed mortality data are not available for all areas covered by the cancer registries (CRs) participating in the EUROCARE-3 study. Materials and methods: Mathematical methods were used to construct complete local mortality data (life tables) for each year of age (0-99), for each year (1978-2000) and by sex, from the incomplete life tables provided by CRs, presenting the results as life expectancy at birth (LE). Socio-economic data were obtained from the United Nations (UN) and Organisation for Economic Co-operation and Development (OECD). Results: The time and regional trends in LE provided by our estimates are closely similar to those published by the UN at the country level. According to UN data, LE (men plus women) varied from 70 years in Estonia to almost 79 years in Sweden in the period 1995-1999. LE increased markedly over the 20-year study period in most countries except Estonia and Denmark. LE correlated directly with GDP, national expenditure on health and relative survival for all cancers combined. We found that within-country LE variation was large in some countries (particularly the UK). Sweden, Iceland, Switzerland, and parts of Spain and Italy had high LE; eastern European countries had low LE. Conclusions: Detailed area-specific life tables are essential for reliable estimation of relative cancer survival and its comparison across populations, since LE varies markedly across Europe. Where not available, life tables can be constructed to the required level of detail using mathematical approaches.

Original languageEnglish (US)
JournalAnnals of Oncology
Volume14
Issue numberSUPPL.5
DOIs
StatePublished - Dec 1 2003
Externally publishedYes

Fingerprint

Life Expectancy
Life Tables
Registries
United Nations
Survival
Estonia
Neoplasms
Sweden
Mortality
Iceland
Denmark
Health Expenditures
Switzerland
Spain
Italy
Cause of Death
Economics
Parturition
Population

Keywords

  • Cancer registries
  • Cancer relative survival
  • Europe
  • Life expectancy at birth

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Micheli, A., Baili, P., Quinn, M., Mugno, E., Capocaccia, R., Grosclaude, P., ... Babb, P. (2003). Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Annals of Oncology, 14(SUPPL.5). https://doi.org/10.1093/annonc/mdg752

Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. / Micheli, Andrea; Baili, P.; Quinn, M.; Mugno, E.; Capocaccia, R.; Grosclaude, P.; Oberaigner, W.; Holub, J.; Jechova, M.; Storm, H.; Engholm, G.; Aareleid, T.; Hakulinen, T.; Soderman, B.; Grosclaude, P.; Spix, C.; Ziegler, H.; Olafsdottir, E.; Capocaccia, R.; Micheli, A.; Baili, P.; Mugno, E.; Dalmas, M.; Tysvaer, S. E.; Pinheiro, Paulo; Rachtan, J.; Bielska-Lasota, M.; Plesko, I.; Pompe-Kirn, V.; Izarzugaza, I.; Martinez-Garcia, C.; Garau, I.; Navarro, C.; Cirera, L.; Ardanaz, E.; Moreno, C.; Galceran, J.; Barlow, L.; Pury, P.; Usel, M.; Visser, O.; Coebergh, J. W.W.; Van Der Heijden, L.; Bhatti, L.; Quinn, M. J.; Babb, P.

In: Annals of Oncology, Vol. 14, No. SUPPL.5, 01.12.2003.

Research output: Contribution to journalArticle

Micheli, A, Baili, P, Quinn, M, Mugno, E, Capocaccia, R, Grosclaude, P, Oberaigner, W, Holub, J, Jechova, M, Storm, H, Engholm, G, Aareleid, T, Hakulinen, T, Soderman, B, Grosclaude, P, Spix, C, Ziegler, H, Olafsdottir, E, Capocaccia, R, Micheli, A, Baili, P, Mugno, E, Dalmas, M, Tysvaer, SE, Pinheiro, P, Rachtan, J, Bielska-Lasota, M, Plesko, I, Pompe-Kirn, V, Izarzugaza, I, Martinez-Garcia, C, Garau, I, Navarro, C, Cirera, L, Ardanaz, E, Moreno, C, Galceran, J, Barlow, L, Pury, P, Usel, M, Visser, O, Coebergh, JWW, Van Der Heijden, L, Bhatti, L, Quinn, MJ & Babb, P 2003, 'Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas', Annals of Oncology, vol. 14, no. SUPPL.5. https://doi.org/10.1093/annonc/mdg752
Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P et al. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Annals of Oncology. 2003 Dec 1;14(SUPPL.5). https://doi.org/10.1093/annonc/mdg752
Micheli, Andrea ; Baili, P. ; Quinn, M. ; Mugno, E. ; Capocaccia, R. ; Grosclaude, P. ; Oberaigner, W. ; Holub, J. ; Jechova, M. ; Storm, H. ; Engholm, G. ; Aareleid, T. ; Hakulinen, T. ; Soderman, B. ; Grosclaude, P. ; Spix, C. ; Ziegler, H. ; Olafsdottir, E. ; Capocaccia, R. ; Micheli, A. ; Baili, P. ; Mugno, E. ; Dalmas, M. ; Tysvaer, S. E. ; Pinheiro, Paulo ; Rachtan, J. ; Bielska-Lasota, M. ; Plesko, I. ; Pompe-Kirn, V. ; Izarzugaza, I. ; Martinez-Garcia, C. ; Garau, I. ; Navarro, C. ; Cirera, L. ; Ardanaz, E. ; Moreno, C. ; Galceran, J. ; Barlow, L. ; Pury, P. ; Usel, M. ; Visser, O. ; Coebergh, J. W.W. ; Van Der Heijden, L. ; Bhatti, L. ; Quinn, M. J. ; Babb, P. / Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. In: Annals of Oncology. 2003 ; Vol. 14, No. SUPPL.5.
@article{7489c88aa9d54b63bb8ce91dc937167f,
title = "Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas",
abstract = "Background: Mortality information is essential for estimating relative cancer survival (that excludes deaths from other causes). However, sufficiently detailed mortality data are not available for all areas covered by the cancer registries (CRs) participating in the EUROCARE-3 study. Materials and methods: Mathematical methods were used to construct complete local mortality data (life tables) for each year of age (0-99), for each year (1978-2000) and by sex, from the incomplete life tables provided by CRs, presenting the results as life expectancy at birth (LE). Socio-economic data were obtained from the United Nations (UN) and Organisation for Economic Co-operation and Development (OECD). Results: The time and regional trends in LE provided by our estimates are closely similar to those published by the UN at the country level. According to UN data, LE (men plus women) varied from 70 years in Estonia to almost 79 years in Sweden in the period 1995-1999. LE increased markedly over the 20-year study period in most countries except Estonia and Denmark. LE correlated directly with GDP, national expenditure on health and relative survival for all cancers combined. We found that within-country LE variation was large in some countries (particularly the UK). Sweden, Iceland, Switzerland, and parts of Spain and Italy had high LE; eastern European countries had low LE. Conclusions: Detailed area-specific life tables are essential for reliable estimation of relative cancer survival and its comparison across populations, since LE varies markedly across Europe. Where not available, life tables can be constructed to the required level of detail using mathematical approaches.",
keywords = "Cancer registries, Cancer relative survival, Europe, Life expectancy at birth",
author = "Andrea Micheli and P. Baili and M. Quinn and E. Mugno and R. Capocaccia and P. Grosclaude and W. Oberaigner and J. Holub and M. Jechova and H. Storm and G. Engholm and T. Aareleid and T. Hakulinen and B. Soderman and P. Grosclaude and C. Spix and H. Ziegler and E. Olafsdottir and R. Capocaccia and A. Micheli and P. Baili and E. Mugno and M. Dalmas and Tysvaer, {S. E.} and Paulo Pinheiro and J. Rachtan and M. Bielska-Lasota and I. Plesko and V. Pompe-Kirn and I. Izarzugaza and C. Martinez-Garcia and I. Garau and C. Navarro and L. Cirera and E. Ardanaz and C. Moreno and J. Galceran and L. Barlow and P. Pury and M. Usel and O. Visser and Coebergh, {J. W.W.} and {Van Der Heijden}, L. and L. Bhatti and Quinn, {M. J.} and P. Babb",
year = "2003",
month = "12",
day = "1",
doi = "10.1093/annonc/mdg752",
language = "English (US)",
volume = "14",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "SUPPL.5",

}

TY - JOUR

T1 - Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas

AU - Micheli, Andrea

AU - Baili, P.

AU - Quinn, M.

AU - Mugno, E.

AU - Capocaccia, R.

AU - Grosclaude, P.

AU - Oberaigner, W.

AU - Holub, J.

AU - Jechova, M.

AU - Storm, H.

AU - Engholm, G.

AU - Aareleid, T.

AU - Hakulinen, T.

AU - Soderman, B.

AU - Grosclaude, P.

AU - Spix, C.

AU - Ziegler, H.

AU - Olafsdottir, E.

AU - Capocaccia, R.

AU - Micheli, A.

AU - Baili, P.

AU - Mugno, E.

AU - Dalmas, M.

AU - Tysvaer, S. E.

AU - Pinheiro, Paulo

AU - Rachtan, J.

AU - Bielska-Lasota, M.

AU - Plesko, I.

AU - Pompe-Kirn, V.

AU - Izarzugaza, I.

AU - Martinez-Garcia, C.

AU - Garau, I.

AU - Navarro, C.

AU - Cirera, L.

AU - Ardanaz, E.

AU - Moreno, C.

AU - Galceran, J.

AU - Barlow, L.

AU - Pury, P.

AU - Usel, M.

AU - Visser, O.

AU - Coebergh, J. W.W.

AU - Van Der Heijden, L.

AU - Bhatti, L.

AU - Quinn, M. J.

AU - Babb, P.

PY - 2003/12/1

Y1 - 2003/12/1

N2 - Background: Mortality information is essential for estimating relative cancer survival (that excludes deaths from other causes). However, sufficiently detailed mortality data are not available for all areas covered by the cancer registries (CRs) participating in the EUROCARE-3 study. Materials and methods: Mathematical methods were used to construct complete local mortality data (life tables) for each year of age (0-99), for each year (1978-2000) and by sex, from the incomplete life tables provided by CRs, presenting the results as life expectancy at birth (LE). Socio-economic data were obtained from the United Nations (UN) and Organisation for Economic Co-operation and Development (OECD). Results: The time and regional trends in LE provided by our estimates are closely similar to those published by the UN at the country level. According to UN data, LE (men plus women) varied from 70 years in Estonia to almost 79 years in Sweden in the period 1995-1999. LE increased markedly over the 20-year study period in most countries except Estonia and Denmark. LE correlated directly with GDP, national expenditure on health and relative survival for all cancers combined. We found that within-country LE variation was large in some countries (particularly the UK). Sweden, Iceland, Switzerland, and parts of Spain and Italy had high LE; eastern European countries had low LE. Conclusions: Detailed area-specific life tables are essential for reliable estimation of relative cancer survival and its comparison across populations, since LE varies markedly across Europe. Where not available, life tables can be constructed to the required level of detail using mathematical approaches.

AB - Background: Mortality information is essential for estimating relative cancer survival (that excludes deaths from other causes). However, sufficiently detailed mortality data are not available for all areas covered by the cancer registries (CRs) participating in the EUROCARE-3 study. Materials and methods: Mathematical methods were used to construct complete local mortality data (life tables) for each year of age (0-99), for each year (1978-2000) and by sex, from the incomplete life tables provided by CRs, presenting the results as life expectancy at birth (LE). Socio-economic data were obtained from the United Nations (UN) and Organisation for Economic Co-operation and Development (OECD). Results: The time and regional trends in LE provided by our estimates are closely similar to those published by the UN at the country level. According to UN data, LE (men plus women) varied from 70 years in Estonia to almost 79 years in Sweden in the period 1995-1999. LE increased markedly over the 20-year study period in most countries except Estonia and Denmark. LE correlated directly with GDP, national expenditure on health and relative survival for all cancers combined. We found that within-country LE variation was large in some countries (particularly the UK). Sweden, Iceland, Switzerland, and parts of Spain and Italy had high LE; eastern European countries had low LE. Conclusions: Detailed area-specific life tables are essential for reliable estimation of relative cancer survival and its comparison across populations, since LE varies markedly across Europe. Where not available, life tables can be constructed to the required level of detail using mathematical approaches.

KW - Cancer registries

KW - Cancer relative survival

KW - Europe

KW - Life expectancy at birth

UR - http://www.scopus.com/inward/record.url?scp=5444225034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5444225034&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdg752

DO - 10.1093/annonc/mdg752

M3 - Article

C2 - 14684499

AN - SCOPUS:5444225034

VL - 14

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - SUPPL.5

ER -